Suppr超能文献

老年疗养院晚期非小细胞肺癌患者的功能状态和生存情况:一项 SEER-Medicare 分析。

Functional Status and Survival in Older Nursing Home Residents With Advanced Non-Small-Cell Lung Cancer: A SEER-Medicare Analysis.

机构信息

Warren Alpert Medical School of Brown University, Providence, RI.

Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, RI.

出版信息

JCO Oncol Pract. 2022 Jun;18(6):e886-e895. doi: 10.1200/OP.21.00460. Epub 2022 Feb 7.

Abstract

PURPOSE

Many older patients with advanced lung cancer have functional limitations and require skilled nursing home care. Function, assessed using activities of daily living (ADL) scores, may help prognostication. We investigated the relationship between ADL impairment and overall survival among older patients with advanced non-small-cell lung cancer (NSCLC) receiving care in nursing homes.

METHODS

Using the SEER-Medicare database linked with Minimum Data Set assessments, we identified patients age 65 years and older with NSCLC who received care in nursing homes from 2011 to 2015. We used Cox regression and Kaplan-Meier survival curves to examine the relationship between ADL scores and overall survival among all patients; among patients who received systemic cancer chemotherapy or immunotherapy within 3 months of NSCLC diagnosis; and among patients who did not receive any treatment.

RESULTS

We included 3,174 patients (mean [standard deviation] age, 77 [7.4] years [range, 65-102 years]; 1,664 [52.4%] of female sex; 394 [12.4%] of non-Hispanic Black race/ethnicity), 415 (13.1%) of whom received systemic therapy, most commonly with carboplatin-based regimens (n = 357 [86%] patients). The median overall survival was 3.1 months for patients with ADL score < 14, 2.8 months for patients with ADL score between 14 and 17, 2.3 months for patients with ADL score between 18-19, and 1.8 months for patients with ADL score 20+ (log-rank < .001). The ADL score was associated with increased risk of death (hazard ratio [HR], 1.20; 95% CI, 1.16 to 1.25 per standard deviation). One standard deviation increase in the ADL score was associated with lower overall survival rate among treated (HR, 1.14; 95% CI, 1.02 to 1.27) and untreated (HR, 1.20; 95% CI, 1.15 to 1.26) patients.

CONCLUSION

ADL assessment stratified mortality outcomes among older nursing home adults with NSCLC, and may be a useful clinical consideration in this population.

摘要

目的

许多患有晚期肺癌的老年患者存在功能受限,需要接受熟练的疗养院护理。使用日常生活活动(ADL)评分评估的功能可能有助于预后判断。我们调查了在疗养院接受护理的老年晚期非小细胞肺癌(NSCLC)患者的 ADL 损伤与总生存之间的关系。

方法

我们使用 SEER-Medicare 数据库与最低数据集评估相关联,确定了 2011 年至 2015 年在疗养院接受护理的年龄在 65 岁及以上的 NSCLC 患者。我们使用 Cox 回归和 Kaplan-Meier 生存曲线检查了所有患者、在 NSCLC 诊断后 3 个月内接受系统癌症化疗或免疫治疗的患者以及未接受任何治疗的患者之间 ADL 评分与总生存之间的关系。

结果

我们纳入了 3174 名患者(平均[标准差]年龄为 77[7.4]岁[范围:65-102 岁];1664[52.4%]为女性;394[12.4%]为非西班牙裔黑人种族/民族),其中 415 名(13.1%)接受了系统治疗,最常见的是基于卡铂的方案(n=357[86%]患者)。ADL 评分<14 的患者中位总生存期为 3.1 个月,ADL 评分在 14-17 之间的患者为 2.8 个月,ADL 评分在 18-19 之间的患者为 2.3 个月,ADL 评分 20+的患者为 1.8 个月(对数秩<.001)。ADL 评分与死亡风险增加相关(风险比[HR],1.20;95%CI,1.16 至 1.25 每标准差)。ADL 评分每增加一个标准差,与接受治疗(HR,1.14;95%CI,1.02 至 1.27)和未接受治疗(HR,1.20;95%CI,1.15 至 1.26)的患者的总生存率降低相关。

结论

ADL 评估使老年疗养院 NSCLC 患者的死亡率分层结果更加明确,这可能是该人群中有用的临床考虑因素。

相似文献

本文引用的文献

1
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021.NCCN 指南®洞察:老年肿瘤学,第 1.2021 版。
J Natl Compr Canc Netw. 2021 Sep 20;19(9):1006-1019. doi: 10.6004/jnccn.2021.0043.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验